Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in Bio-Techne by 1.8% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 16,347 shares of the ...
Finally, Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in Bio-Techne by 1.8% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 16,347 shares ...
The most notable increase was in Bio-Techne Corp (NASDAQ:TECH), with an additional 334,050 shares, bringing the total to 381,250 shares. This adjustment represents a significant 707.73% increase in ...
The S&P 500 Index ($SPX) (SPY) today is up +0.73%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.27%, and the Nasdaq ...
Introduction Blood cancer diagnostics refers to the process of detecting and identifying cancers that affect the blood, bone marrow, and lympha ...
Bio-Techne (TECH) is down more than -5% to lead makers of lab-tool ... is down more than -2% after Susquehanna Financial ...
Bio-Techne during Q4, while other hedge funds adjusted their holdings.,Many market reports reflect an optimistic view of ...
Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools, is pleased to announce the official release of GMP Transposase mRNA for the TcBuster™ non-viral ...
Bio-Techne (TECH) announced the launch of an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research and the development of next-generation ...
Shares of Bio-Techne Corporation (NASDAQ:TECH) traded higher after the life sciences company topped analysts' expectations with its Q2 FY25 results, indicating a faster topline growth amid early ...